Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies

NCT05262777 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT05262777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05262777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0112 for Cheek Augmentation and Correction of Midface Contour Deficiencies
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
May 2, 2022
Completion date
March 5, 2024
Enrollment
211 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

cheek wrinkles, midface contour deficiencies